---
title: "OnKure Therapeutics, Inc. (OKUR.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/OKUR.US.md"
symbol: "OKUR.US"
name: "OnKure Therapeutics, Inc."
industry: "Biotechnology"
---

# OnKure Therapeutics, Inc. (OKUR.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [onkuretherapeutics.com](https://onkuretherapeutics.com) |

## Company Profile

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harborin...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.58 | 150/606 | - | - | - |
| PB | 0.55 | 36/606 | 0.58 | 0.48 | 0.36 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-10T05:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 6 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.26 |
| Highest Target | 34.00 |
| Lowest Target | 30.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/OKUR.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/OKUR.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/OKUR.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.